PFIZER INC (PFE) - Price, trends, fundamentals and chart - Passport to Wall Street

PFIZER INC (NYSE: PFE)

Overview

current price

$49.71

$49.71

change

-1.02 | -2.01%

-1.02 | -2.01%

Yesterday's Close

50.73

open

50.67

volume

21.79 M

30d. avg volume.

20.85 M

1 day

49.18 - 50.85

52 weeks

41.45 - 61.71

p/e

9.72

beta

0.6987

market cap

284.76 B

dividend yield

3.15%

Industry

-

News and Commentary

Market Update: Stocks Slide Ahead of Fed's November Policy Decision Stocks fell on Tuesday to open November on a low note as market participants anxiously awaited the Federal Reserve's upcoming monetary policy decision. The Dow Jones Industrial A...

CDC Recommends Novavax COVID Shots as Mix-and-Match Third Dose Booster The U.S. Centers for Disease Control and Prevention (CDC) recommended Novavax

CDC, FDA Sign Off on Updated COVID Booster Shots for Children The U.S. Centers for Disease Control and Prevention (CDC) on Wednesday recommended updated Omicron-targeting COVID boosters for Americans as young as 5-years-old, seeking to incr...

Pfizer, Moderna Seek FDA Authorization for Bivalent COVID Boosters for Younger Americans Younger children may soon be eligible to receive an Omicron-target booster shot later this year, following U.S. Food and Drug Administration (FDA) applications from Pfizer ...

FDA Authorizes Updated COVID Boosters Targeting Omicron The U.S. Food and Drug Administration (FDA) this week authorized updated COVID boosters from Pfizer

CDC Eases COVID Guidelines for Quarantine, Marking New Phase of Pandemic The U.S. Centers for Disease Control and Prevention (CDC) has recently eased its COVID-19 guidance...

White House Plans "Operation Warp Speed 2" for Next-Gen COVID Vaccines At this point, the coronavirus has been with us for nearly 3 years, and the rate of new infections in some areas is even higher now than it was at this time last year. The purpos...

CDC Signs Off on Novavax COVID Vaccine as Fourth Primary Series Available in U.S. The U.S. Centers for Disease Control and Prevention (CDC) backed Novavax's

U.S. COVID Hospitalizations Double Since Early May as Omicron BA.5 Spreads The number of COVID hospitalizations have doubled since early May as more transmissible subvariants of the already highly contagious Omicron variant--called BA.4 and BA.5--spread...

Merck Set to Pay $40 Billion for Seagen Cancer-Focused Biotech Company Pharmaceutical giant Merck & Co. (

StockTwits

Join now and unlock premium features

Access to premium stock and ETF data including financials, holdings and more
Participate in trading contests and earn real prizes
Sync you favorite articles and symbols between all of your device
And much more